Synvista Therapeutics, Inc.
Limited financial coverage for SYNI.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
Price Chart
About the company
Synvista Therapeutics, Inc. functions as a biopharmaceutical company dedicated to creating both diagnostic tools and therapeutic drugs. Its core objective is to identify and provide treatment options for diabetic patients who are at an elevated risk of developing cardiovascular disease.
- IPO
- 2000
- Employees
- 9
- HQ
- Parsippany, US
Get TickerSpark's AI analysis on SYNI
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -5.15
- RSI (14)
- 39
- Avg Volume
- 260
No earnings-call transcripts are available for SYNI yet.
- Free Float
- 93.9%
- Shares Outstanding
- 2.59M
- Float Shares
- 2.43M
Our SYNI coverage
Recent articles, reports, and earnings notes.
No research on SYNI yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SYNI report →